MIT-affiliated companies take on Covid-19
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.
Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.
An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.
Area hospitals in need of PPE look to university labs and departments for donations.
With help from artificial intelligence, researchers identify hidden power of vitamin A and ordinary chewing gum glaze.
Microfluidics enables researchers to create unique environment for developing medicine, paving the way for more potent, high-quality drugs.
A variety of MIT research projects could aid efforts to detect and prevent the spread of coronavirus.
Study shows removing liability concerns slightly increases C-section procedures during childbirth.
A new model can predict which types of glucose-responsive insulin will work in humans and animals.
Dimagi’s data-collection platform has helped improve health care for hundreds of millions of people around the world.
Study finds that in Liberia, volunteers limited damage from Ebola by distributing information within their own communities.
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
The MIT Humanitarian Supply Chain lab led a blended supply chain management course with Addis Ababa University.
Research underscores infection is not a common hospital transmission.
Findings could help researchers design drugs to treat influenza B infections.